Kerry R. Hicks
CIK: 0001110473
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TLSI
TriSalus Life Sciences, Inc.
Director
Discretionary Trading P&L
Holdings
About HICKS KERRY R
HICKS KERRY R (SEC CIK 0001110473) files insider reports with the SEC as Director of TriSalus Life Sciences, Inc. (TLSI).
Signal8 holds 2 ownership filings by HICKS KERRY R, all Form 4s, filed between Jun 27, 2025 and May 15, 2026. Those filings report 2 transactions, from Jun 12, 2025 to May 14, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on HICKS KERRY R's filings is in EVERGREEN, CO.
Recent filings by HICKS KERRY R
Other insiders filing for TriSalus Life Sciences, Inc. (TLSI)
- Cox Bryan F., Chief of Research
- Marshak Richard, Chief Commercial Officer
- Stevens Jennifer, Chief Regulatory Officer
- Szela Mary T, CEO and President
- Patience David, Chief Financial Officer
- Marshall Richard Henry, Chief Medical Officer